291 related articles for article (PubMed ID: 24375392)
1. Recent progress on nutraceutical research in prostate cancer.
Li Y; Ahmad A; Kong D; Bao B; Sarkar FH
Cancer Metastasis Rev; 2014 Sep; 33(2-3):629-40. PubMed ID: 24375392
[TBL] [Abstract][Full Text] [Related]
2. Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
McCarty MF; Hejazi J; Rastmanesh R
Integr Cancer Ther; 2014 Sep; 13(5):386-95. PubMed ID: 24867960
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.
Abd Wahab NA; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32131560
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
6. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.
Singh-Gupta V; Banerjee S; Yunker CK; Rakowski JT; Joiner MC; Konski AA; Sarkar FH; Hillman GG
Cancer Lett; 2012 May; 318(1):86-92. PubMed ID: 22155105
[TBL] [Abstract][Full Text] [Related]
7. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer stem cells by nutraceuticals for cancer therapy.
Chu M; Zheng C; Chen C; Song G; Hu X; Wang ZW
Semin Cancer Biol; 2022 Oct; 85():234-245. PubMed ID: 34273521
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
10. Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.
Wang Z; Fan J; Liu M; Yeung S; Chang A; Chow MS; Pon D; Huang Y
Expert Opin Investig Drugs; 2013 Dec; 22(12):1613-26. PubMed ID: 24050482
[TBL] [Abstract][Full Text] [Related]
11. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.
Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R
Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970
[TBL] [Abstract][Full Text] [Related]
12. Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.
Lee CH; Decker AM; Cackowski FC; Taichman RS
Cell Biol Toxicol; 2020 Apr; 36(2):115-130. PubMed ID: 31250347
[TBL] [Abstract][Full Text] [Related]
13. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
[TBL] [Abstract][Full Text] [Related]
14. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.
Fontana F; Raimondi M; Marzagalli M; Di Domizio A; Limonta P
Cells; 2020 Feb; 9(2):. PubMed ID: 32085497
[TBL] [Abstract][Full Text] [Related]
15. Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells.
Qian S; Fang H; Zheng L; Liu M
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22611. PubMed ID: 32905641
[TBL] [Abstract][Full Text] [Related]
16. Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.
Kallifatidis G; Hoy JJ; Lokeshwar BL
Semin Cancer Biol; 2016 Oct; 40-41():160-169. PubMed ID: 27370570
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
19. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
20. Novel targets for prostate cancer chemoprevention.
Sarkar FH; Li Y; Wang Z; Kong D
Endocr Relat Cancer; 2010 Sep; 17(3):R195-212. PubMed ID: 20576802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
